Day: January 31, 2024

Tilray’s Fan-Favorite Breweries Have Big Game Beers for the Biggest Football Game of the YearTilray Beer BrandsTilray Brands Beer PortfolioNEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) — As football fans gear up for the biggest showdown of the year, Tilray Brands, (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading cannabis lifestyle and craft beer and beverage, consumer product goods company, is unveiling its craft beer locks for the big game. Whether you’re looking for a crispy, juicy, or hoppy brew, Tilray’s acclaimed craft breweries across the country have you covered. From east to west and north to south, Tilray’s BIG GAME BEERS are serving up the perfect brews for gameday on Feb 11th.10 Barrel Pub Beer: We could go into fancy descriptions, such as herbal spice, grassy, green apple,...

WAUKESHA, Wis., Jan. 31, 2024 (GLOBE NEWSWIRE) — Generac Holdings Inc. (“Generac”) (NYSE: GNRC), a leading global designer and manufacturer of energy technology solutions and other power products, today announced plans to release its fourth quarter and full-year 2023 financial results before the market opens on Wednesday, February 14, 2024. Generac management will hold a conference call at 10:00 a.m. EST on that day to discuss highlights of this earnings release. The conference call can be accessed at the following link: https://register.vevent.com/register/BIedddb843f9564021bf0d57eb7e31888f. Individuals that wish to listen via telephone will be given dial-in information. The conference call will also be webcast simultaneously on Generac’s website (http://www.generac.com), under the Investor Relations link. The webcast...

Boston, Jan. 31, 2024 (GLOBE NEWSWIRE) — Amwell® (NYSE: AMWL), a leader in digital healthcare enablement, will report its fourth quarter 2023 operating results on Wednesday, Feb. 14.  Following the distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company’s operating results and provide a general business update.  The audio webcast can be accessed by visiting the Investors section of the company’s website. Alternatively, participants can call (888) 510-2008 (U.S.) or (646) 960-0306 (International) to listen to the live conference call. The call ID number is 7830032.   A webcast replay of the call will be available at investors.amwell.com for approximately 90 days.  About Amwell   Amwell is a leading hybrid care delivery...

Figure 1:Church Project exploration resultsFigure 2:Kamuck Property, showing eU responses and individual samples on prospected areas identified by aerial imagery– Company Selected to Receive $200,000 Ontario Government Grant – VANCOUVER, British Columbia, Jan. 31, 2024 (GLOBE NEWSWIRE) — Solstice Gold Corp. (TSXV: SGC) (“Solstice”, “we”, “our” or the “Company”) is pleased to provide an update on the exploration program at its Church and Kamuck Projects in the Quetico Subprovince, located approximately 85 km and 200 km NE of Thunder Bay, Ontario, respectively in the actively explored Quetico lithium district. Emerging Quetico Lithium District Spodumene discoveries reported by exploration groups in 2023 are defining a greatly expanded area with high lithium potential within the Quetico subprovince. The Quetico Lithium...

Beijing, Jan. 31, 2024 (GLOBE NEWSWIRE) — WeTrade Information Technology Limited, a wholly-owned subsidiary of WeTrade Group Inc.（WETG.US） in Hong Kong, and Beijing YueShang digital Technology Group Co., LTD, a wholly-owned subsidiary of China, jointly declare that:The announcement made by WeTrade Group Inc. on November 21, 2023 that the two companies have been sold is not true. The two companies will file a lawsuit through legal and demand economic compensation from WeTrade Group Inc.Mr. Hechun Wei, the former CEO of WeTrade Group Inc. , also stated in his clarification letter that during his tenure as CEO of WeTrade Group Inc., he did not sigh any announcement to sell these two companies. About WeTrade Information Technology Limited WeTrade Information Technology Limited is a technology research and development company for the...

Finance Calendar 2024 28th February 2024: Interim report Q4 2023 (no annual account) 30th April 2024: Annual Account 30th April 2024: Annual General Meeting 31th May 2024: Interim report Q1 2024 30th Aug 2024: Interim report Q2 2024 29th Nov 2024: Interim report Q3 2024AttachmentCompany announcement no 2 Finance Calender update

Mont-Saint-Guibert, Belgium, January 31, 2024, 7.00 am CEST – BioSenic (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, today announces that it will attend and support the upcoming GvHGvL Meeting on 13-15 March, 2024 at University Hospital Regensburg, a biannual conference to lead scientific exchange around graft-versus-host disease (GvHD). GvHD can result from transplanting bone marrow or stem cells from a donor to a patient. BioSenic is planning a Phase 3 study of its first-in-class oral arsenic trioxide (OATO) therapy in patients with chronic GvHD (cGvHD), a focus area for the company. The trial will test OATO as a first-line therapy for cGvHD and will begin enrolling the first of about 150 patients over three continents this year. After consulting...